Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (9488)	4/1/1999 8:38:00 AM
From: Tharos	Respond to of 17367

Speaking of Bayer: *** Bayer boosts investment in U.S. R&D PITTSBURGH (AP) - Bayer Corp., the U.S. subsidiary of Germany-based Bayer Group, said Wednesday it would add $6 billion through 2004 to research and development and capital spending for its U.S. operations. The additional investment would bring to $15 billion the total the company is investing in developing U.S. businesses since announcing a $9 billion investment in 1995. The spending is part of a major effort to increasing Bayer's share of the North American consumer market, said Helge H. Wehmeier, president and chief executive of the Pittsburgh-based Bayer Corp. Bayer believes it can grab more of the U.S. market for consumer drugs, medical diagnostic equipment and chemicals, but it is not likely to grow much in Europe. See infobeat.com